Company: SCLXW
Filing Date: 2025-02-14
Form Type: PRE 14A
Source: 0001193125-25-027244
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-02-14
Form: PRE 14A
Chunk 3
---
 Restated Certificate of Incorporation (the                                                                                                                                                                                                         
 “Certificate of Incorporation”) to effect a reverse stock split of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), within a range of 1-for-14 to 1-for-30 (or any number in between), without reducing the authorized number of shares of the Common Stock, and the 
 filing of a final amendment with the ratio within such range to be determined in the sole discretion of the Board of Directors of the Company (the “Board”) at any time on or before March 19, 2026, without further approval or authorization                                                    
 of our stockholders (the “Reverse Stock Split Proposal”); and                                                                                                                                                                                                                                     |

| • |     | the approval of an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there 
 are not sufficient votes in favor of the Reverse Stock Split Proposal (the “Adjournment Proposal”).         |

Why is the Company seeking approval for the Reverse Stock Split Proposal? On November 1, 2024, we received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last 30 consecutive business days, the bid price for the Common Stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have been provided an initial period of 180 calendar days, or until April 30, 2025, to regain compliance with the minimum bid price requirement. As of the date hereof, we have not regained compliance with the minimum bid price requirement since the closing bid price of the Common Stock has not been at least $1.00 per share for a minimum of 10 consecutive business days. To cure the deficiency, we may conduct the reverse stock split of the Common Stock for which we are seeking stockholder approval in this Proxy Statement. On , 2025, the closing price of our Common Stock as reported on the Nasdaq Capital Market was $ per share. Our Board has approved the reverse stock split as a potential means of increasing the share price of the Common Stock and may choose to implement it if other options are unavailable, undesirable, or insufficient. Our Board 1

believes that maintaining our listing on the Nasdaq Capital Market provides a broader market for the Common Stock and facilitates the use of the